Skip to main content

Table 1 Bortezomib and celecoxib cohort dosing schedules

From: Bortezomib in combination with celecoxib in patients with advanced solid tumors: a phase I trial

Cohorts

Bortezomib (mg/m2)

Bortezomib days of administration

Celecoxib (mg PO bid)

Level 1

1.0

1, 8, 15, 22, 29 q42 days

200

Level 2

1.0

1, 4, 8, 11 q21 days

200

Level 3

1.3

1, 8, 15, 22, 29 q42 days

300

Level 4

1.3

1, 4, 8, 11 q21 days

300

Level 5

1.6

1, 8, 15, 22, 29 q42 days

400

Level 6

1.3

1, 4, 8, 11 q21 days

400